Discussion about this post

User's avatar
Daniel Bruetman MD, MMM's avatar

She’s so sneaky that she hedges by claiming it’s what the experts are saying and she’s just the messenger. This is beyond poor reporting, it’s irresponsible for the NYT to publish it. If they want to do investigative reporting on misinformation, they don’t need to go very far.

Jack McJackers's avatar

“The question is whether there is a reduction in severe disease, hospitalization and death. This was shown to be the case in randomized trials for the first 2 doses in late 2020 and early 2021. “

If I’m not mistaken, RCTs did NOT show an all-cause mortality benefit for the first two doses. More people in the intervention group does vs. controls...not a hell of a lot more, but more.

Bad oversight by VP.

28 more comments...

No posts

Ready for more?